Results for &quot;&quot;Etiocholanolone&quot;&quot;[mesh_terms]

Steroid metabolism and excretion in severe anorexia nervosa: effects of refeeding.

Wassif S Wassif, Declan M McLoughlin, Royce P Vincent, Simon Conroy, Gerald F M Russell, Norman F Taylor

The American journal of clinical nutrition 2011;93(5):911-7

Energetic analysis of binding of progesterone and 5 beta-androstane-3,17-dione to anti-progesterone antibody DB3 using molecular dynamics and free energy calculations.

M Peräkylä, N Nordman

Protein engineering 2002;14(10):753-8

Urinary excretion of steroid metabolites after chronic androstenedione ingestion.

Matthew D Vukovich, Douglas S King, Gregory A Brown

The Journal of clinical endocrinology and metabolism 2005;89(12):6235-8

Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial.

Sanjiv J Shah, John E A Blair, Gerasimos S Filippatos, Cezar Macarie, Witold Ruzyllo, Jerzy Korewicki, Serban I Bubenek-Turconi, Maurizio Ceracchi, Maria Bianchetti, Paolo Carminati, Dimitrios Kremastinos, Jacek Grzybowski, Giovanni Valentini, Hani N Sabbah, Mihai Gheorghiade

American heart journal 2009;157(6):1035-41

Newer inotropes in pediatric heart failure.

Timothy M Hoffman

Journal of cardiovascular pharmacology 2011;58(2):121-5

Effects of resistance training on testosterone metabolism in younger and older men.

Juha P Ahtiainen, Kai Nyman, Ilpo Huhtaniemi, Tapani Parviainen, Mika Helste, Antti Rannikko, William J Kraemer, Keijo Häkkinen

Experimental gerontology 2016;69():148-58

Overview of emerging pharmacologic agents for acute heart failure syndromes.

Leonardo De Luca, Alexandre Mebazaa, Gerasimos Filippatos, John T Parissis, Michael Böhm, Adriaan A Voors, Markku Nieminen, Faiez Zannad, Andrew Rhodes, Ali El-Banayosy, Kenneth Dickstein, Mihai Gheorghiade

European journal of heart failure 2008;10(2):201-13

Emerging therapies for the management of decompensated heart failure: from bench to bedside.

Emil M deGoma, Randall H Vagelos, Michael B Fowler, Euan A Ashley

Journal of the American College of Cardiology 2007;48(12):2397-409

Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure.

Mihai Gheorghiade, John E A Blair, Gerasimos S Filippatos, Cezar Macarie, Witold Ruzyllo, Jerzy Korewicki, Serban I Bubenek-Turconi, Maurizio Ceracchi, Maria Bianchetti, Paolo Carminati, Dimitrios Kremastinos, Giovanni Valentini, Hani N Sabbah

Journal of the American College of Cardiology 2008;51(23):2276-85

A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic function.

Jalal K Ghali, William B Smith, Guillermo Torre-Amione, William Haynos, Barry K Rayburn, Antonino Amato, Dan Zhang, Doug Cowart, Giovanni Valentini, Paolo Carminati, Mihai Gheorghiade

The American journal of cardiology 2007;99(2A):47A-56A

Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond.

John R Teerlink, Marco Metra, Valerio Zacà, Hani N Sabbah, Gadi Cotter, Mihai Gheorghiade, Livio Dei Cas

Heart failure reviews 2010;14(4):243-53